Manaksia targeting overseas mkt for better paced growth

Published on Tue, Jan 08, 2008 at 10:00 |  Source : CNBC-TV18

Updated at Tue, Jan 08, 2008 at 15:20  

2470 Investors following Manaksia. Share this News with them.
0
0
Share on Tumblr
Basant Kumar, MD, Manaksia Limited

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

RELATED NEWS

Manaksia has listed at Rs 180, a premium of 12.5% over its offer price of Rs 160 per share. Speaking exclusively to CNBC-TV18, Basant Kumar , MD, Manaksia Limited said that their FY09 sales target which stands at Rs 1200 crore is achievable. He added that they are targeting the overseas market and that their growth will be better paced. According to Kumar, their packaging revenue stands at 15%. He added that they do not foresee a margin squeeze.

 

Manaksia's client list includes Coco Cola, Shaw Wallace and UB.

 

Excerpts of CNBC-TV18's exclusive interview with Basant Kumar:

 

Q: We have got a target from analysts who tracks your company of Rs 1,200 crore in sales next year i.e. FY09 and about Rs 140 crore in profits. Do you think that's achievable?

 

A: That target is definitely achievable. I don't have any doubt about it.

 

Q: If you indeed end up doing Rs 1200 crore in sales next year, what geographies would that revenue be split between - Nigeria, Nepal and other markets?

 

A: Our revenue of more than 50% is coming from outside India. We feel that the growth of Manaksia will be more from overseas market. We are targeting overseas market where we feel the company is going to grow at a much better pace.

 

Q: How much of that Rs 1,200 crore revenues is coming in purely from your packaging products and who are your key clients right now?

 

A: Packaging is not our major business story.  Our major business is value added metal products, mainly aluminium and steel. Value added aluminium is our major driver which contribute to around 78% of revenue and from packaging we are getting a revenue of only 15%.

 

Our major customers in packaging are Coca Cola India, Reckitt & Colman, UB and Shaw Wallace.     

 

Q: You have a mosquito coil business. How large is that and where do you market that, within the domestic market i.e. India or the other markets?

 

A: We are the largest player in the mosquito coil business and in fact, 60% of India market is with us. We are manufacturing mosquito coil for Mortein, Maxo, Jyothy Lab and Reckitt & Colman. We are also doing it for Eveready where the total share of our business is only 12%.

 

Q: What are you doing about the raw material front? If you are in a value added business, you do not manufacture the primary metal. Is that likely to squeeze margins or do you have any backward integration plans?

 

A: We do not foresee any squeeze in margins. The basic reason for this is that we are in a value added product wherein we buy our raw material at LME plus and we sell at LME plus, so our margins are more or less constant.

  

More on Moneycontrol

Trending News

Business News

How to Root and install Custom Recovery on any Android phone
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com